|
Jul 28
|
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
|
|
Jul 25
|
Venous Thromboembolism Treatment Devices Market Insights, Competitive Landscape, and Forecast Report 2032 Featuring Abbott, Boston Scientific, AngioDynamics, Argon Medical Devices, and Medtronic
|
|
Jul 23
|
AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology
|
|
Jul 18
|
Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments
|
|
Jul 17
|
AngioDynamics Full Year 2025 Earnings: Beats Expectations
|
|
Jul 16
|
ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines
|
|
Jul 16
|
AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ...
|
|
Jun 23
|
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
|
|
Jun 9
|
ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
|
|
Jun 9
|
Zacks Industry Outlook Penumbra, Integer and AngioDynamics
|
|
Jun 6
|
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
|
|
Jun 6
|
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
|
|
Jun 5
|
Here's Why You Should Add PacBio Stock to Your Portfolio Now
|
|
Jun 4
|
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
|
|
Jun 4
|
What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?
|
|
May 28
|
NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
|
|
May 28
|
Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
|
|
May 26
|
BioSig Stock Surges Following Share Exchange Deal With Streamex
|
|
May 23
|
Reasons to Retain TransMedics Stock in Your Portfolio for Now
|
|
May 22
|
AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech
|